Breakthrough blood test could spot dangerous virus earlier in vulnerable transplant patients
NCT ID NCT07181330
Summary
This study tested a new blood test designed to detect cytomegalovirus (CMV) infection in people who have received a stem cell transplant. Researchers looked back at stored blood samples from 60 transplant patients to see if the new test, which looks for a specific viral marker, works better than the current standard test. The goal is to find infections earlier and more accurately to help doctors start treatment sooner.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CYTOMEGALOVIRUS INFECTIONS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
The First Affiliated Hospital of Fujian Medical University
Fuzhou, Fujian, 350001, China
Conditions
Explore the condition pages connected to this study.